$AGIO
Agios Pharmaceuticals Inc

2019 Q3 Form 10-Q Financial Statement

#000143922219000017 Filed on August 01, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue $26.02M $26.22M $40.41M
YoY Change 71.23% -35.12% 256.2%
Cost Of Revenue $393.0K $303.0K $0.00
YoY Change -43.45%
Gross Profit $25.63M $25.92M $40.41M
YoY Change 76.73% -35.87%
Gross Profit Margin 98.49% 98.84% 100.0%
Selling, General & Admin $33.02M $32.39M $26.63M
YoY Change 6.17% 21.63% 65.1%
% of Gross Profit 128.83% 124.97% 65.89%
Research & Development $101.7M $107.4M $86.73M
YoY Change 23.15% 23.82% 8.66%
% of Gross Profit 396.68% 414.34% 214.6%
Depreciation & Amortization $2.100M $2.000M $1.800M
YoY Change 16.67% 11.11% 12.5%
% of Gross Profit 8.19% 7.72% 4.45%
Operating Expenses $135.1M $140.1M $113.4M
YoY Change 18.12% 23.57% 18.15%
Operating Profit -$109.1M -$113.9M -$72.95M
YoY Change 9.98% 56.08% -13.77%
Interest Expense $2.890M $3.990M $4.200M
YoY Change -35.78% -5.0% 176.32%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$106.2M -$109.9M -$68.75M
YoY Change 12.16% 59.81% -17.25%
Income Tax
% Of Pretax Income
Net Earnings -$106.2M -$109.9M -$68.75M
YoY Change 12.16% 59.82% -17.26%
Net Earnings / Revenue -407.98% -419.02% -170.1%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.806M -$1.871M -$1.191M
COMMON SHARES
Basic Shares Outstanding 58.75M shares 58.71M shares 57.61M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $451.9M $495.4M $716.9M
YoY Change -32.54% -30.9% 22.34%
Cash & Equivalents $81.71M $83.58M $210.3M
Short-Term Investments $370.2M $411.8M $506.6M
Other Short-Term Assets $20.00M $19.10M $15.50M
YoY Change 21.21% 23.23% 19.23%
Inventory $5.849M $4.659M
Prepaid Expenses
Receivables $9.700M $9.800M $1.600M
Other Receivables $2.700M $4.800M $19.70M
Total Short-Term Assets $490.1M $533.7M $753.8M
YoY Change -29.53% -29.2% 24.66%
LONG-TERM ASSETS
Property, Plant & Equipment $24.06M $23.02M $24.13M
YoY Change -2.25% -4.63% -2.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $88.60M $128.6M $219.7M
YoY Change -57.51% -41.47% 69.13%
Other Assets $0.00 $0.00 $595.0K
YoY Change -100.0% -100.0% -52.36%
Total Long-Term Assets $208.5M $250.2M $244.5M
YoY Change -10.73% 2.34% 56.78%
TOTAL ASSETS
Total Short-Term Assets $490.1M $533.7M $753.8M
Total Long-Term Assets $208.5M $250.2M $244.5M
Total Assets $698.6M $783.9M $998.2M
YoY Change -24.81% -21.47% 31.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.51M $15.44M $17.32M
YoY Change 29.46% -10.88% -26.01%
Accrued Expenses $46.75M $49.22M $25.79M
YoY Change 84.76% 90.82% -12.98%
Deferred Revenue $16.87M $18.45M
YoY Change -59.96%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $92.43M $89.50M $84.87M
YoY Change 9.07% 5.46% -9.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $157.9M $161.7M $90.20M
YoY Change 87.75% 79.27% -42.91%
Total Long-Term Liabilities $157.9M $161.7M $90.20M
YoY Change 87.75% 79.27% -42.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $92.43M $89.50M $84.87M
Total Long-Term Liabilities $157.9M $161.7M $90.20M
Total Liabilities $250.3M $251.2M $175.1M
YoY Change 48.24% 43.46% -30.41%
SHAREHOLDERS EQUITY
Retained Earnings -$1.414B -$1.308B -$918.2M
YoY Change 39.58% 42.41% 45.13%
Common Stock $1.862B $1.840B $1.744B
YoY Change 4.87% 5.51% 52.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $448.3M $532.7M $823.1M
YoY Change
Total Liabilities & Shareholders Equity $698.6M $783.9M $998.2M
YoY Change -24.81% -21.47% 31.24%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$106.2M -$109.9M -$68.75M
YoY Change 12.16% 59.82% -17.26%
Depreciation, Depletion And Amortization $2.100M $2.000M $1.800M
YoY Change 16.67% 11.11% 12.5%
Cash From Operating Activities -$85.60M -$88.10M -$67.40M
YoY Change 34.17% 30.71% 14.24%
INVESTING ACTIVITIES
Capital Expenditures -$2.000M -$1.300M -$1.400M
YoY Change -35.48% -7.14% 40.0%
Acquisitions
YoY Change
Other Investing Activities $82.50M $65.70M -$94.90M
YoY Change 1298.31% -169.23% -65.44%
Cash From Investing Activities $80.40M $64.40M -$96.30M
YoY Change 2771.43% -166.87% -65.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.300M 3.800M 9.500M
YoY Change -54.17% -60.0% -96.52%
NET CHANGE
Cash From Operating Activities -85.60M -88.10M -67.40M
Cash From Investing Activities 80.40M 64.40M -96.30M
Cash From Financing Activities 3.300M 3.800M 9.500M
Net Change In Cash -1.900M -19.90M -154.2M
YoY Change -96.47% -87.09% 150.32%
FREE CASH FLOW
Cash From Operating Activities -$85.60M -$88.10M -$67.40M
Capital Expenditures -$2.000M -$1.300M -$1.400M
Free Cash Flow -$83.60M -$86.80M -$66.00M
YoY Change 37.73% 31.52% 13.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
649-8600
dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.001 per share
dei Entity Registrant Name
EntityRegistrantName
AGIOS PHARMACEUTICALS INC
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001439222
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36014
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0662915
dei Entity Address Address Line1
EntityAddressAddressLine1
88 Sidney Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02139
dei Trading Symbol
TradingSymbol
AGIO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58752886 shares
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83580000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70502000 USD
CY2019Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
411810000 USD
CY2018Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
514800000 USD
CY2019Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7147000 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
5076000 USD
CY2019Q2 agio Collaboration Receivable Duefrom Related Parties Current
CollaborationReceivableDuefromRelatedPartiesCurrent
2524000 USD
CY2018Q4 agio Collaboration Receivable Duefrom Related Parties Current
CollaborationReceivableDuefromRelatedPartiesCurrent
2462000 USD
CY2019Q2 agio Collaboration Receivable Other Current
CollaborationReceivableOtherCurrent
2222000 USD
CY2018Q4 agio Collaboration Receivable Other Current
CollaborationReceivableOtherCurrent
670000 USD
CY2019Q2 agio Royalty Receivable Duefrom Related Parties Current
RoyaltyReceivableDuefromRelatedPartiesCurrent
2700000 USD
CY2018Q4 agio Royalty Receivable Duefrom Related Parties Current
RoyaltyReceivableDuefromRelatedPartiesCurrent
2234000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
4659000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
869000 USD
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19063000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17167000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
533705000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
613780000 USD
CY2019Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
128649000 USD
CY2018Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
220119000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
98500000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23016000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24320000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
238000 USD
CY2019Q2 us-gaap Assets
Assets
783870000 USD
CY2018Q4 us-gaap Assets
Assets
858457000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
15435000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17880000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49218000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42147000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18454000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32710000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6397000 USD
CY2019Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
0 USD
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
766000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
89504000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
93503000 USD
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
51616000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
59809000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
110073000 USD
CY2019Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
0 USD
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
17608000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
251193000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
170920000 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58749186 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58749186 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58218653 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58218653 shares
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
59000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
58000 USD
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1839710000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1794283000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
490000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2171000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1307582000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1104633000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
532677000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
687537000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
783870000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
858457000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26221000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40414000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56448000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49176000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
303000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
637000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
107389000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
86730000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
202974000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
164954000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32390000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26633000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64181000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51183000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
140082000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
113363000 USD
us-gaap Operating Expenses
OperatingExpenses
267792000 USD
us-gaap Operating Expenses
OperatingExpenses
216137000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-113861000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-72949000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-211344000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-166961000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3990000 USD
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
4204000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
8395000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
7391000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-109871000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-68745000 USD
us-gaap Net Income Loss
NetIncomeLoss
-202949000 USD
us-gaap Net Income Loss
NetIncomeLoss
-159570000 USD
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.87
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.19
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.46
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.81
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58722244 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
57721786 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58589167 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56713795 shares
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-109871000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-68745000 USD
us-gaap Net Income Loss
NetIncomeLoss
-202949000 USD
us-gaap Net Income Loss
NetIncomeLoss
-159570000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
974000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
245000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2661000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1009000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-108897000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-68500000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-200288000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-160579000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
687537000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6003000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18108000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1687000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-93078000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
620257000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2770000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18547000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
974000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-109871000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
532677000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
375503000 USD
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
516206000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12332000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14522000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1254000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-90825000 USD
CY2018Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-346000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
865594000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9638000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16455000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
245000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-68745000 USD
CY2018Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
-45000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
823142000 USD
us-gaap Net Income Loss
NetIncomeLoss
-202949000 USD
us-gaap Net Income Loss
NetIncomeLoss
-159570000 USD
us-gaap Depreciation
Depreciation
4042000 USD
us-gaap Depreciation
Depreciation
3464000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
36655000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
30977000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2019000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1291000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
20000 USD
agio Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
4208000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2071000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 USD
agio Increase Decreasein Collaboration Receivable Duefrom Related Parties Current
IncreaseDecreaseinCollaborationReceivableDuefromRelatedPartiesCurrent
62000 USD
agio Increase Decreasein Collaboration Receivable Duefrom Related Parties Current
IncreaseDecreaseinCollaborationReceivableDuefromRelatedPartiesCurrent
16878000 USD
agio Increase Decreasein Collaboration Receivable Other Current
IncreaseDecreaseinCollaborationReceivableOtherCurrent
1552000 USD
agio Increase Decreasein Collaboration Receivable Other Current
IncreaseDecreaseinCollaborationReceivableOtherCurrent
440000 USD
agio Increase Decreasein Royalty Receivable Duefrom Related Parties Current
IncreaseDecreaseinRoyaltyReceivableDuefromRelatedPartiesCurrent
466000 USD
agio Increase Decreasein Royalty Receivable Duefrom Related Parties Current
IncreaseDecreaseinRoyaltyReceivableDuefromRelatedPartiesCurrent
351000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3790000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2517000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2413000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1874000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6198000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
7071000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-7841000 USD
agio Increase Decrease In Contract With Customer Liability Related Party
IncreaseDecreaseInContractWithCustomerLiabilityRelatedParty
-22449000 USD
agio Increase Decrease In Contract With Customer Liability Related Party
IncreaseDecreaseInContractWithCustomerLiabilityRelatedParty
-10644000 USD
agio Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3649000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
16000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-191422000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-166395000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
144231000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
592664000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
343372000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
331666000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3309000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2793000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
195832000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-263791000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
391000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
516206000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8668000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
21970000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8668000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
537785000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13078000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107599000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70502000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102724000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83580000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
210323000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
535000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1365000 USD
agio Proceeds From Stock Options Exercised In Other Current Assets
ProceedsFromStockOptionsExercisedInOtherCurrentAssets
112000 USD
agio Proceeds From Stock Options Exercised In Other Current Assets
ProceedsFromStockOptionsExercisedInOtherCurrentAssets
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
42856000 USD
CY2019Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
624000000.0 USD
CY2018Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2019Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
539858000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
889000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
288000 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
540459000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
737090000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
33000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2204000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
734919000 USD
CY2019Q2 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
79 security
CY2018Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
242 security
CY2019Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
175500000 USD
CY2018Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
639300000 USD
CY2019Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
180000 USD
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
0 USD
CY2019Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4392000 USD
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
788000 USD
CY2019Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
87000 USD
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
81000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
4659000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
869000 USD
agio Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P9Y
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3800000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
6800000 USD
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3200000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
6300000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5695000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
14015000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
14380000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
16773000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
18126000 USD
CY2019Q2 agio Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
18660000 USD
CY2019Q2 agio Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
63891000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
151540000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.057
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y8M12D
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
151540000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
35070000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
116470000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
12759000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
13135000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
13473000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
15552000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
17145000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
19223000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
91287000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10541000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20843000 USD
CY2019Q2 agio Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
30189000 USD
CY2018Q4 agio Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
14777000 USD
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6357000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5441000 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2131000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1086000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49218000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42147000 USD
CY2018Q4 agio Contract With Customer Contractual Adjustment Reserve
ContractWithCustomerContractualAdjustmentReserve
592000 USD
CY2018Q4 agio Contract With Customer Rebate Reserve
ContractWithCustomerRebateReserve
325000 USD
CY2018Q4 agio Contract With Customer Right To Recover Product Reserve
ContractWithCustomerRightToRecoverProductReserve
334000 USD
CY2018Q4 agio Contract With Customer Total Allowances And Reserves
ContractWithCustomerTotalAllowancesAndReserves
1251000 USD
agio Current Year Provision For Contractual Adjustments
CurrentYearProvisionForContractualAdjustments
3145000 USD
agio Current Year Provisions For Rebate Reserve
CurrentYearProvisionsForRebateReserve
820000 USD
agio Provision For Right To Recover Product In Current Year
ProvisionForRightToRecoverProductInCurrentYear
586000 USD
agio Contract With Customer Current Year Reserve Provisions
ContractWithCustomerCurrentYearReserveProvisions
4551000 USD
agio Prior Year Provision For Contractual Adjustments
PriorYearProvisionForContractualAdjustments
8000 USD
agio Prior Year Provisions For Rebate Reserve
PriorYearProvisionsForRebateReserve
0 USD
agio Provision For Right To Recover Product In Prior Years
ProvisionForRightToRecoverProductInPriorYears
0 USD
agio Contract With Customer Prior Years Reserve Provisions
ContractWithCustomerPriorYearsReserveProvisions
8000 USD
agio Contract With Customer Contract Adjustment Recoveries Current Year
ContractWithCustomerContractAdjustmentRecoveriesCurrentYear
2450000 USD
agio Contract With Customer Rebate Reserve Recoveries In Current Year
ContractWithCustomerRebateReserveRecoveriesInCurrentYear
355000 USD
agio Contract With Customer Right To Recover Product Current Year Recoveries
ContractWithCustomerRightToRecoverProductCurrentYearRecoveries
0 USD
agio Contract With Customer Current Year Reserve Recoveries
ContractWithCustomerCurrentYearReserveRecoveries
2805000 USD
agio Contract With Customer Contract Adjustment Recoveries Prior Year
ContractWithCustomerContractAdjustmentRecoveriesPriorYear
598000 USD
agio Contract With Customer Rebate Reserve Recoveries In Prior Years
ContractWithCustomerRebateReserveRecoveriesInPriorYears
230000 USD
agio Contract With Customer Right To Recover Product Prior Year Recoveries
ContractWithCustomerRightToRecoverProductPriorYearRecoveries
0 USD
agio Contract With Customer Prior Years Reserve Recoveries
ContractWithCustomerPriorYearsReserveRecoveries
828000 USD
CY2019Q2 agio Contract With Customer Contractual Adjustment Reserve
ContractWithCustomerContractualAdjustmentReserve
697000 USD
CY2019Q2 agio Contract With Customer Rebate Reserve
ContractWithCustomerRebateReserve
560000 USD
CY2019Q2 agio Contract With Customer Right To Recover Product Reserve
ContractWithCustomerRightToRecoverProductReserve
920000 USD
CY2019Q2 agio Contract With Customer Total Allowances And Reserves
ContractWithCustomerTotalAllowancesAndReserves
2177000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
416000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
326000 USD
CY2019Q2 agio Contract With Customer Allowance And Reserves Liability
ContractWithCustomerAllowanceAndReservesLiability
1761000 USD
CY2018Q4 agio Contract With Customer Allowance And Reserves Liability
ContractWithCustomerAllowanceAndReservesLiability
925000 USD
CY2019Q2 agio Contract With Customer Total Allowances And Reserves
ContractWithCustomerTotalAllowancesAndReserves
2177000 USD
CY2018Q4 agio Contract With Customer Total Allowances And Reserves
ContractWithCustomerTotalAllowancesAndReserves
1251000 USD
CY2018Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
5076000 USD
agio Contractwith Customer Asset Revenue Recognized
ContractwithCustomerAssetRevenueRecognized
27395000 USD
agio Contract With Customer Asset Proceeds From Collection Of Receivables
ContractWithCustomerAssetProceedsFromCollectionOfReceivables
25324000 USD
CY2019Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7147000 USD
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8009000 USD
CY2018Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9932000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
24419000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
15917000 USD
CY2019Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 USD
CY2018Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
220000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
543000 USD
CY2019Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
75500000 USD
agio Revenue From Contracts With Customers Milestone Revenue Recognized
RevenueFromContractsWithCustomersMilestoneRevenueRecognized
0 USD
CY2018Q2 agio Revenue From Contracts With Customers Milestone Revenue Recognized
RevenueFromContractsWithCustomersMilestoneRevenueRecognized
0 USD
agio Revenue From Contracts With Customers Milestone Revenue Recognized
RevenueFromContractsWithCustomersMilestoneRevenueRecognized
0 USD
CY2019Q2 agio Revenue From Contracts With Customers Milestone Revenue Recognized
RevenueFromContractsWithCustomersMilestoneRevenueRecognized
0 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5416069 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
60.10
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18547000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1464728 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
57.08
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
181010 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
38.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
356493 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
66.38
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6343294 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
59.66
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3414953 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
58.63
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6343294 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
59.66
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18547000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16455000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36655000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30977000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16455000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36655000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30977000 USD
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7113868 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7113868 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6166573 shares
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6166573 shares

Files In Submission

Name View Source Status
0001439222-19-000017-index-headers.html Edgar Link pending
0001439222-19-000017-index.html Edgar Link pending
0001439222-19-000017.txt Edgar Link pending
0001439222-19-000017-xbrl.zip Edgar Link pending
agio-20190630.htm Edgar Link pending
agio-20190630.xsd Edgar Link pending
agio-20190630_cal.xml Edgar Link unprocessable
agio-20190630_def.xml Edgar Link unprocessable
agio-20190630_htm.xml Edgar Link completed
agio-20190630_lab.xml Edgar Link unprocessable
agio-20190630_pre.xml Edgar Link unprocessable
exhibit10-1x06x30x19.htm Edgar Link pending
exhibit10-2x06x30x19.htm Edgar Link pending
exhibit10-3x06x30x19.htm Edgar Link pending
exhibit31-1x06x30x19.htm Edgar Link pending
exhibit31-2x06x30x19.htm Edgar Link pending
exhibit32-1x06x30x19.htm Edgar Link pending
exhibit32-2x06x30x19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
parkimages.jpg Edgar Link pending
premisesimage.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending